Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
63%(5 trials)

Phase Distribution

Ph phase_2
5
63%
Ph phase_1
3
38%

Phase Distribution

3

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 2Efficacy & side effects
5(62.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (37.5%)
Phase 25 (62.5%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

NCT03607487
completedphase_2

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

NCT04476043
completedphase_1

A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

NCT05624710
completedphase_2

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

NCT05061693
completedphase_2

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo

NCT04818346
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03607487Phase 2

A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Completed
NCT04476043Phase 2

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Completed
NCT05624710Phase 1

A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Completed
NCT05061693Phase 2

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

Completed
NCT04818346Phase 2

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo

Completed
NCT05624723Phase 1

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis

Completed
NCT03569371Phase 2

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Completed
NCT05068466Phase 1

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of INCB054707

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8